New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.
Cat.No. | Product Name | Activity |
4659 | Floxuridine | Inhibitor of thymidylate synthetase; anticancer agent |
4657 | Zolmitriptan | Potent 5-HT1B/1D/1F agonist |
4639 | TT 232 | sst1/sst4 somatostatin receptor agonist |
4653 | ML 171 | Selective NADPH oxidase 1 (NOX1) inhibitor |
4650 | I-BET 151 hydrochloride | BET bromodomain inhibitor |
4641 | BI 6015 | Hepatocyte nuclear factor 4α (HNF4α) antagonist |
4582 | MLR 1023 | Selective allosteric activator of Lyn kinase |
4530 | ONO 2506 | Inhibits S100B synthesis; neuroprotective |
4507 | ML 218 hydrochloride | Ca2+ channel blocker (T-type) |
4104 | MM-22 | Biotinylated anandamide analog; blocks anandamide uptake |
4652 | SAHA | Class I and II HDAC inhibitor |
4607 | LM 22A4 | Potent TrkB agonist |
4592 | R8-T198wt | Pim-1 kinase inhibitor |
4542 | (+)-Fluprostenol | High affinity FP prostaglandin receptor agonist |
4433 | Pluripotin | Dual ERK1/RasGAP inhibitor. Maintains ESC self-renewal |